Search - tctmd.com

Displaying 441 - 460 of 719

Sort: Relevancy | Date

News Conference News ACC 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

Shelley Wood

March 17, 2019

News Daily News

FDA Extends MitraClip Indication to Include Functional MR

Shelley Wood

March 14, 2019

News Industry News

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

March 14, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Industry News

Innovative Cardiovascular Solutions Announces First Use of its Next-Generation Emblok™ Embolic Protection System in European Feasibility Study

March 05, 2019

News Conference News CRT 2019

BASILICA Leaflet Laceration Before TAVR Helps Prevent Coronary Obstruction

Yael L. Maxwell

March 04, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Daily News

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

Yael L. Maxwell

March 01, 2019

News Daily News

Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort

L.A. McKeown

February 14, 2019

News Conference News STS 2019

TAVR-Related Complications, High Resource Use Decreasing at a Surgeon-Led Program

Yael L. Maxwell

January 30, 2019

News Daily News

FDA Approves Pea-Sized Occluder for Patent Ductus Arteriosus in Premature Babies

L.A. McKeown

January 14, 2019

News Daily News

Appropriate Use Criteria Tackle Imaging in Nonvalvular Structural Heart Disease

Caitlin E. Cox

January 07, 2019

News Daily News

MitraClip Analysis Highlights Questions of Patient Selection in Functional MR

Shelley Wood

January 04, 2019

News Daily News

Tricuspid Valve Interventions in High-Risk Patients: Midterm Outcomes Encouraging in TriValve Registry

Caitlin E. Cox

January 04, 2019

News Features

Top News in Structural Heart Disease: 2018

L.A. McKeown

December 28, 2018

News Daily News

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Yael L. Maxwell

December 10, 2018

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Todd Neale

November 20, 2018

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

News Daily News

PFO Closure Registry Confirms Risk of New-Onset A-fib

Yael L. Maxwell

November 09, 2018

News Conference News VIVA 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

L.A. McKeown

November 09, 2018

Advertisement

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

FDA Extends MitraClip Indication to Include Functional MR

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Innovative Cardiovascular Solutions Announces First Use of its Next-Generation Emblok™ Embolic Protection System in European Feasibility Study

BASILICA Leaflet Laceration Before TAVR Helps Prevent Coronary Obstruction

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort

TAVR-Related Complications, High Resource Use Decreasing at a Surgeon-Led Program

FDA Approves Pea-Sized Occluder for Patent Ductus Arteriosus in Premature Babies

Appropriate Use Criteria Tackle Imaging in Nonvalvular Structural Heart Disease

MitraClip Analysis Highlights Questions of Patient Selection in Functional MR

Tricuspid Valve Interventions in High-Risk Patients: Midterm Outcomes Encouraging in TriValve Registry

Top News in Structural Heart Disease: 2018

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

PFO Closure Registry Confirms Risk of New-Onset A-fib

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content